Histone Deacetylase 3 (HDAC3) Regulates Lymphatic Vascular Development
Cardiovascular disease continues to be the leading cause of morbidity and mortality worldwide with an estimated 17 million annual deaths. A majority of cases are attributed to disease affecting the vascular system including arterial, venous and lymphatic vessels. Despite progress in understanding th...
Main Author: | Palleti Janardhan, Harish P. |
---|---|
Format: | Others |
Published: |
eScholarship@UMMS
2018
|
Subjects: | |
Online Access: | https://escholarship.umassmed.edu/gsbs_diss/1001 https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2009&context=gsbs_diss |
Similar Items
-
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
by: Giorgio Milazzo, et al.
Published: (2020-05-01) -
Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
by: Elizabeth A. Thomas
Published: (2014-05-01) -
The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors
by: Fangyuan Cao, et al.
Published: (2018-03-01) -
Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis
by: Min Young Kim, et al.
Published: (2020-11-01) -
Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus
by: Xiaojie Wang, et al.
Published: (2012-08-01)